Altrinsic Global Advisors’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Altrinsic Global Advisors’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-376,900	Closed	-$716K	–	76
2021 Q4	$716K	Hold	376,900	–	–	0.02%	69
2021 Q3	$1.13M	Hold	376,900	–	–	0.03%	70
2021 Q2	$1.47M	Hold	376,900	–	–	0.04%	68
2021 Q1	$1.91M	Buy	376,900 +40,000	+12%	+$208K	0.06%	69
2020 Q4	$1.38M	Hold	336,900	–	–	0.05%	70
2020 Q3	$1.64M	Hold	336,900	–	–	0.07%	58
2020 Q2	$1.87M	Hold	336,900	–	–	0.08%	56
2020 Q1	$1.1M	Buy	336,900 +30,000	+10%	+$158K	0.06%	64
2019 Q4	$1.39M	Hold	306,900	–	–	0.06%	60
2019 Q3	$1.28M	Hold	306,900	–	–	0.06%	63
2019 Q2	$1.16M	Hold	306,900	–	–	0.05%	74
2019 Q1	$1.29M	Buy	306,900 +60,000	+24%	+$210K	0.06%	71
2018 Q4	$615K	Hold	246,900	–	–	0.03%	78
2018 Q3	$1.8M	Hold	246,900	–	–	0.08%	65
2018 Q2	$914K	Hold	246,900	–	–	0.04%	75
2018 Q1	$951K	Buy	246,900 +17,900	+8%	+$75.2K	0.04%	73
2017 Q4	$824K	Hold	229,000	–	–	0.03%	75
2017 Q3	$905K	Hold	229,000	–	–	0.03%	75
2017 Q2	$1.17M	Hold	229,000	–	–	0.04%	76
2017 Q1	$1.58M	Buy	229,000 +10,000	+5%	+$78.1K	0.05%	71
2016 Q4	$2.05M	Hold	219,000	–	–	0.08%	66
2016 Q3	$2.14M	Buy	219,000 +20,000	+10%	+$270K	0.08%	67
2016 Q2	$2.81M	Hold	199,000	–	–	0.08%	67
2016 Q1	$2.78M	Hold	199,000	–	–	0.08%	70
2015 Q4	$4.06M	Buy	199,000 +30,000	+18%	+$463K	0.11%	66
2015 Q3	$2.22M	Buy	169,000 +5,000	+3%	+$82.9K	0.05%	73
2015 Q2	$2.52M	Buy	164,000 +10,000	+6%	+$192K	0.05%	74
2015 Q1	$3.08M	Buy	154,000 +111,500	+262%	+$2.49M	0.07%	68
2014 Q4	$893K	Buy	+42,500	New	+$865K	0.02%	76

Other funds holding AGTC

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Altrinsic Global Advisors's AGTC Position: Q1 2022 in Review

Altrinsic Global Advisors sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2022, closing a stake of 376,900 shares — an estimated $716K sold.

Altrinsic Global Advisors first reported a position in AGTC in Q4 2014 and held it in 29 quarters. The position peaked at $4.06M in Q4 2015. 53 funds tracked by Wall St. Rank hold AGTC as of Q1 2022.

Altrinsic Global Advisors reported no remaining Applied Genetic Technologies Corporation position as of Q1 2022 after selling out during the quarter.
Altrinsic Global Advisors sold 376,900 Applied Genetic Technologies Corporation shares in Q1 2022, an estimated $716K.
Altrinsic Global Advisors first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 29 quarters.
Altrinsic Global Advisors's Applied Genetic Technologies Corporation position peaked at $4.06M in Q4 2015.
53 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2022.

Based on Altrinsic Global Advisors's 13F filing for Q1 2022, filed 16 May 2022.